BioCentury
ARTICLE | Translation in Brief

Translational tidbits

December 19, 2013 8:00 AM UTC

GlaxoSmithKline plc has set up an immuno-oncology consortium that invites academics from six cancer centers to view its nonpublic early pipeline programs and share ideas for new therapeutic candidates.

The Oncology Clinical and Translational Consortium (OCTC) includes the Gustave Roussy Institute, The University of Texas MD Anderson Cancer Center, the Memorial Sloan-Kettering Cancer Center, the Netherlands Cancer Institute, the Princess Margaret Cancer Centre and the Vall d'Hebron Institute of Oncology...